Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates

Sarepta Therapeutics (SRPT) came out with a quarterly loss of $3.42 per share versus the Zacks Consensus Estimate of $0.35. This compares to earnings of $0.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1,077.14%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.87 per share when it actually produced earnings of $1.50, delivering a surprise of -19.79%.Over the last four quarters ...